Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 610,820 | 681,184 | 632,124 | 681,110 | 676,844 |
| Cost of Goods | 284,854 | 314,821 | 296,441 | 318,627 | 314,427 |
| Gross Profit | 325,966 | 366,363 | 335,683 | 362,483 | 362,417 |
| Operating Expenses | 282,112 | 271,867 | 245,175 | 273,493 | 300,931 |
| Operating Income | 44,708 | 95,317 | 90,949 | 89,617 | 61,913 |
| Interest Expense | 12,277 | 12,361 | 12,398 | 12,343 | 12,337 |
| Other Income | 458,647 | 345,436 | 58,551 | -1,577,701 | 35,253 |
| Pre-tax Income | 491,078 | 428,392 | 137,102 | -1,500,427 | 84,829 |
| Income Tax | 107,162 | 78,684 | 30,845 | -338,176 | 15,867 |
| Net Income Continuous | 383,916 | 349,708 | 106,257 | -1,162,251 | 68,962 |
| Net Income | $383,916 | $349,708 | $106,257 | $-1,162,251 | $68,962 |
| EPS Basic Total Ops | 13.46 | 11.79 | 3.65 | -39.59 | 2.33 |
| EPS Basic Continuous Ops | 13.46 | 11.79 | 3.65 | -39.59 | 2.33 |
| EPS Diluted Total Ops | 13.45 | 11.81 | 3.64 | -39.59 | 2.32 |
| EPS Diluted Continuous Ops | 13.45 | 11.82 | 3.64 | -39.59 | 2.32 |
| EPS Diluted Before Non-Recurring Items | 2.29 | 3.10 | 2.33 | 3.00 | 3.34 |
| EBITDA(a) | $44,708 | $95,317 | $90,949 | $89,617 | $61,913 |